Elizabeth O. Ofili, MD, MPH, FACC
Morehouse School of Medicine
Dr. Elizabeth O. Ofili is a professor of medicine (cardiology) and senior associate dean for clinical and translational research at Morehouse School of Medicine. A national and internationally recognized clinician-scientist with a particular focus on cardiovascular disparities and women’s health, Dr. Ofili has been continuously funded by the NIH and industry/foundations since 1994, with a track record in clinical trials that impact health disparities. She is the founder of AccuHealth Technologies, which is dedicated to “empowering patient-centered health and wellness.”
In 2002, as president of the Association of Black Cardiologists, she led the initiative to implement the landmark African American Heart Failure Trial, whose findings led to a change in practice guidelines for the treatment of heart failure in African Americans.
Dr Ofili holds a patent for “A system and method for chronic illness care,” and is the recipient of over 20 national and international awards, including the 2003 National Library of Medicine’s “Changing the Face of Medicine, the Rise of America’s Women,” The Daniel Savage Memorial Science Award from the Association of Black Cardiologists, she was named one of America’s Top Doctors by Black Enterprise magazine, and was named one of 100 Most Influential Healthcare Leaders by the Atlanta Business Chronicle. Dr. Ofili has delivered over 600 scientific presentations and published over 130 scientific papers in national and international journals.
Dr. Ofili graduated with distinction from Ahmadu Bello University in Nigeria, completed internal medicine residency at Oral Roberts University in Tulsa, Oklahoma; cardiology fellowship at Washington University in St Louis; and advanced echocardiography research fellowship at St. Louis University.
